Last A$1.27 AUD
Change Today +0.025 / 2.00%
Volume 180.7K
NAN On Other Exchanges
As of 12:11 AM 01/28/15 All times are local (Market data is delayed by at least 15 minutes).

nanosonics ltd (NAN) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/2/15 - A$1.45
52 Week Low
02/17/14 - A$0.74
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NANOSONICS LTD (NAN)

Related News

No related news articles were found.

nanosonics ltd (NAN) Related Businessweek News

No Related Businessweek News Found

nanosonics ltd (NAN) Details

Nanosonics Limited, together with its subsidiaries, is engaged in the research, development, and commercialization of infection control and decontamination products, and related technologies. The company also manufactures and distributes trophon EPR ultrasound probe disinfector, and its associated consumables and accessories for use in the treatment of healthcare-acquired infections. It operates in North America, Australia, New Zealand, Europe, and other countries. The company was incorporated in 2000 and is based in Alexandria, Australia.

Founded in 2000

nanosonics ltd (NAN) Top Compensated Officers

Chief Executive Officer, President, Managing ...
Total Annual Compensation: A$332.8K
Chief Financial Officer and Company Secretary
Total Annual Compensation: A$308.8K
Chief Operations Officer
Total Annual Compensation: A$241.1K
Head of Research, Design and Development
Total Annual Compensation: A$198.6K
Head of Global Support and Services
Total Annual Compensation: A$168.8K
Compensation as of Fiscal Year 2014.

nanosonics ltd (NAN) Key Developments

Nanosonics Announces Address Change

Nanosonics announced it will be moving in the second half of 2015 to new global corporate and manufacturing facilities. Currently based in Alexandria, Sydney, NSW, Nanosonics will be moving to 14 Mars Road, Lane Cove, NSW, the former Global Headquarters of Cochlear Limited. The new headquarters provide the organisation with more than double its existing space with the opportunity for further expansion in the future. Having all operations on a single site compared to the current seven unit structure in Alexandria provides great opportunities for improved efficiencies across the business. The new facility is also in an ideal location being a hub for many medical technology organisations.

Nanosonics Limited - Shareholder/Analyst Call

Nanosonics Limited - Shareholder/Analyst Call

Nanosonics Limited Reports Earnings Results for the First Quarter Ended September 30, 2014

Nanosonics Limited reported earnings results for the first quarter ended September 30, 2014. For the quarter, the company reported sales were $6.01 million, up 19% on the prior corresponding period $5.07 million. Cash flow positive in the first quarter with cash at the end of the quarter totaling $23.56 million compared with $21.23 million as at 30 June 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NAN:AU A$1.27 AUD +0.025

NAN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NAN.
View Industry Companies

Industry Analysis


Industry Average

Valuation NAN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 12.9x
Price/Book 13.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 11.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NANOSONICS LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at